Provided by Tiger Trade Technology Pte. Ltd.

Amgen

429.88
-2.5400-0.59%
Post-market: 433.003.12+0.73%19:56 EDT
Volume:2.34M
Turnover:1.01B
Market Cap:231.48B
PE:26.70
High:431.85
Open:428.59
Low:426.00
Close:432.42
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:1.13
T/O Rate:0.44%
Dividend:9.80
Dividend Rate:2.28%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:19.81
PE(LYR):30.21

Loading ...

Sino Biopharmaceutical Stock Falls 1.7% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 03

Amgen Finds No Material Impact From Cybersecurity Incident

MT Newswires Live
·
Aug 01

Amgen Says Proprietary Data, Patient Health Info were Exfiltrated in Cyber Incident

Dow Jones
·
Aug 01

Amgen Discloses Data Breach, Says Patient Information was Stolen

Reuters
·
Aug 01

Amgen says cybersecurity incident not likely to have material impact

TIPRANKS
·
Aug 01

Amgen - Determines Cybersecurity Incident is Material as of July 29, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 01

Amgen - Identifies Unauthorized Activity in Third-Party Cloud Environments in July 2026 - SEC Filing

THOMSON REUTERS
·
Aug 01

Amgen - Reports Exfiltration of Proprietary and Patient Data from Cloud Environments - SEC Filing

THOMSON REUTERS
·
Aug 01

Amgen - Reports no Impact to Products, Operations, or Financial Reporting from Incident - SEC Filing

THOMSON REUTERS
·
Aug 01

How Investors May Respond To Amgen (AMGN) Repatha Expansion and 2026 Dividend Declaration

Simply Wall St.
·
Jul 31

RBC Capital Remains a Buy on Amgen (AMGN)

TIPRANKS
·
Jul 31

Amgen Keeps Quarterly Dividend at $2.52 a Share, Payable Sept. 11 to Holders of Record Aug. 21

MT Newswires Live
·
Jul 31

Amgen Declares USD 2.52/share Q3 2026 Dividend

Reuters
·
Jul 31

Amgen Announces 2026 Third Quarter Dividend

THOMSON REUTERS
·
Jul 31

Press Release: AMGEN Announces 2026 THIRD Quarter Dividend

Dow Jones
·
Jul 31

Amgen Halts Key Bemarituzumab Gastric Cancer Trial, Narrowing Near-Term Upside for AMGN

TIPRANKS
·
Jul 30

Amgen Says EU CHMP Backs Broader Repatha Use to Cut First Heart Attack, Stroke Risk

Reuters
·
Jul 29

Amgen - Chmp Adopts Positive Opinion for Amgen's Repatha (Evolocumab)

THOMSON REUTERS
·
Jul 29

Amgen is Maintained at Equal-Weight by Barclays

Dow Jones
·
Jul 29

Amgen price target raised to $360 from $350 at Barclays

TIPRANKS
·
Jul 29